These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22554965)

  • 21. The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathy.
    Smith TJ
    Eye (Lond); 2019 Feb; 33(2):200-205. PubMed ID: 30385883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Tong BD; Xiao MY; Zeng JX; Xiong W
    Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2021 update on thyroid-associated ophthalmopathy.
    Neag EJ; Smith TJ
    J Endocrinol Invest; 2022 Feb; 45(2):235-259. PubMed ID: 34417736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
    Paik JS; Cho WK; Oh EH; Lee SB; Yang SW
    Mol Vis; 2012; 18():1467-77. PubMed ID: 22736938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.
    Smith TJ; Hegedüs L; Douglas RS
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):291-302. PubMed ID: 22632366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.
    Smith TJ; Tsai CC; Shih MJ; Tsui S; Chen B; Han R; Naik V; King CS; Press C; Kamat S; Goldberg RA; Phipps RP; Douglas RS; Gianoukakis AG
    Thyroid; 2008 Sep; 18(9):983-8. PubMed ID: 18788919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association.
    Chatzistefanou KI; Samara C; Asproudis I; Brouzas D; Moschos MM; Tsianta E; Piaditis G
    Clin Interv Aging; 2017; 12():359-366. PubMed ID: 28243072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDK2-enhanced glycolysis promotes fibroblast proliferation in thyroid-associated ophthalmopathy.
    Ma R; Gan L; Ren H; Harrison A; Qian J
    J Mol Endocrinol; 2020 Nov; 65(4):163-174. PubMed ID: 33086191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased generation of fibrocytes in thyroid-associated ophthalmopathy.
    Douglas RS; Afifiyan NF; Hwang CJ; Chong K; Haider U; Richards P; Gianoukakis AG; Smith TJ
    J Clin Endocrinol Metab; 2010 Jan; 95(1):430-8. PubMed ID: 19897675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-Like Growth Factor Pathway and the Thyroid.
    Smith TJ
    Front Endocrinol (Lausanne); 2021; 12():653627. PubMed ID: 34149612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.
    Li B; Guo J; Wang F; Cheng S; Zeng L
    Exp Eye Res; 2020 Dec; 201():108276. PubMed ID: 32991886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].
    Chen XL; He WM; Li W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):727-731. PubMed ID: 29130665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid.
    Kook KH; Choi YH; Kim YR; Park SJ; Jou I; Kim SJ; Lee SY
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):264-73. PubMed ID: 20811057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy.
    Papageorgiou KI; Hwang CJ; Chang SH; Jarullazada I; Chokron Garneau H; Ang MJ; King AJ; Mancini R; Douglas RS; Goldberg RA
    Arch Ophthalmol; 2012 Mar; 130(3):319-28. PubMed ID: 22411661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.
    Wang Y; Smith TJ
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1735-48. PubMed ID: 24651704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent expression of IL-1 receptor antagonists in CD34⁺ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation.
    Li B; Smith TJ
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2783-90. PubMed ID: 23633206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
    Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
    Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
    Byun JS; Moon NJ; Lee JK
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
    Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
    J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-38 Exerts Anti-Inflammatory and Antifibrotic Effects in Thyroid-Associated Ophthalmopathy.
    Shi L; Ye H; Huang J; Li Y; Wang X; Xu Z; Chen J; Xiao W; Chen R; Yang H
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3125-e3142. PubMed ID: 33693700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.